Sudeep Pharma Limited (BOM:544619)

Market Cap	69.47B
Revenue (ttm)	6.17B +34.4%
Net Income	1.68B +26.3%
EPS	15.40 +25.4%
Shares Out	n/a
PE Ratio	41.30
Forward PE	36.86
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,406
Average Volume	26,662
Open	602.00
Previous Close	615.10
Day's Range	601.55 - 618.10
52-Week Range	524.95 - 795.80
Beta	n/a
RSI	50.56
Earnings Date	Aug 19, 2026

About Sudeep Pharma

Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in United States, Europe, United Kingdom, and Latin America. The company provides mineral salts, such as calcium, zinc, iron, potassium, magnesium, sodium, and copper to a range of health-focused applications; and calcium carbonate, which is used as an active pharmaceutical ingredient for various therapeutic applications. It also offers micronutrient premixes, encapsulated ingredients, liposomal and spray-drie...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1989
• Employees: 740
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544619

Financial Performance

In fiscal year 2025, Sudeep Pharma's revenue was 5.02 billion, an increase of 9.30% compared to the previous year's 4.59 billion. Earnings were 1.39 billion, an increase of 4.14%.